)
Edge17 Oct 2025
A Castle in the Sky: The Story of Oracle
Oracle's journey from database innovator to disciplined enterprise backbone, now shaping the AI buildout with a standardized cloud infrastructure.
Vivos Therapeutics (VVOS) investor relations material
Vivos Therapeutics Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2025 earnings summary19 Aug, 2025
Executive summary
Completed the acquisition of The Sleep Center of Nevada (SCN) in June 2025, marking a strategic pivot to a direct patient and sleep center provider-based model and away from legacy VIP enrollment revenue.
SCN generated $500,000 in diagnostic revenue in the last 20 days of Q2 2025, with strong patient demand exceeding current capacity.
Initial integration of SCN has exceeded expectations, with strong buy-in from medical staff and higher-than-forecast patient demand for alternatives to CPAP.
Management is actively pursuing additional acquisitions and management agreements, including a new agreement with MISleep Solutions in Michigan, to expand the alliance model.
The business model shift away from VIP dentist enrollments led to a decline in legacy service revenue.
Financial highlights
Q2 2025 revenue was $3.8M, down 6% year-over-year, with six-month revenue at $6.8M, and gross margin declined to 55% from 65% in Q2 2024.
Operating loss widened to $4.9M in Q2 2025 and $8.8M for the first half, reflecting higher expenses and lower revenues during the transition.
Net loss for Q2 2025 was $5.0M, with net loss per share of $0.55; accumulated deficit reached $113.1M as of June 30, 2025.
Cash and cash equivalents stood at $4.4M as of June 30, 2025, with total liabilities of $21.5M and stockholders' equity of $4.6M.
Secured $11.5M in net cash from debt and equity financing, including $8.2M in senior secured notes and $3.7M in private placement.
Outlook and guidance
Management expects revenue growth and higher-margin, more sustainable revenue as SO teams and new alliances are deployed, but acknowledges the new model is unproven and subject to risks.
Targets cash flow positivity by Q4 2025, contingent on rapid SO team deployment and facility expansion.
Additional growth initiatives include expanding diagnostic and treatment services, launching a pediatric OSA program, and collaborating with specialty medical groups.
There is substantial doubt about the ability to continue as a going concern without additional financing.
When will Vivos be cash flow positive?
Elaborate on pediatric OSA program plans.
Discuss SO team deployment timeline.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Vivos Therapeutics earnings date
Q3 202513 Nov, 2025
Next Vivos Therapeutics earnings date
Q3 202513 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Company Research17 Oct 2025
Beneath the Surface: A Conversation with Epiroc CEO Helena Hedblom
Legacy, innovation, and leading one of Sweden's most influential industrial companies into a new era.
)
Investor Relations14 Oct 2025
Boost Your Earnings Season Strategy With Real‑Time Alerts
Quartr Pro provides real time alerts, trend analysis and live coverage, giving analysts and investors instant insights to act faster in earnings.
Frequently asked questions
Vivos Therapeutics Inc is a medical technology company focused on the development and commercialization of treatments for sleep-disordered breathing, including obstructive sleep apnea. The company offers oral appliance therapy supported by a network of dental and medical providers. Its approach emphasizes non-invasive, daytime treatments. Vivos Therapeutics Inc is headquartered in Littleton, Colorado, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage